|
| |
 |
| DARZALEX |
דארזלקס |
|
|
|
|
| כן, יש ללחוץ כאן לפירוט |
בסל הבריאות?: |
|
|
| Darzalex as monotherapy is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma, whose prior therapy included a proteasome inhibitor and an immunomodulatory agent and who have demonstrated disease progression on the last therapyDarzalexis indicated in combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone,for the treatment of adult patients with multiple myeloma who have received at least one prior therapyDarzalex in combination with bortezomib, melphalan, and prednisone for the treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant |
התוויה מאושרת: |
|
| CONCENTRATE FOR SOLUTION FOR INFUSION |
דרך מתן:
|
|
| J-C HEALTH CARE LTD |
בעל רישום: |
|
| 157-75-34719-00 |
מספר רישום:
|
|
|
|
|
|
|
 |
INFO ON THE WEB |
מידע ברשת |
|
|
|
|
|
